Click here to visit Vernalis plc.

Berwyn, Pennsylvania based Vernalis Therapeutics, Inc. Vernalis plc announces today that the US Food and Drug Administration FDA has issued a Complete Response Letter CRL regarding the New Drug Application NDA for CCP For more information on Vernalis, click below to download a copy of our fact sheet.

To report SUSPECTED ADVERSE REACTIONS, contact Vernalis Therapeutics, Inc. Home About Us Overview Our people Senior management. Media contacts Latest releases.

Hughes Optioneering

Maps and Directions Contact Form. Latest News FDA Issues a Complete Response Letter on CCP NDA Vernalis plc announces today that the US Food and Drug Administration FDA has issued a Complete Response Letter CRL regarding the New Drug Application NDA for CCP Fact Sheet For more information on Vernalis, click below to download a copy of our fact sheet.

Contact Vernalis Therapeutics T: Company registration and address details Terms and conditions Glossary Privacy policy.